Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine—Results from the Italian ‘Back to Life’ project-Reference-Cited by-同舟云学术

Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine—Results from the Italian ‘Back to Life’ project

Published:2018-03-08 Issue:6 Volume:27 Page:1545-1554
ISSN:0962-9343
Container-title:Quality of Life Research
language:en
Short-container-title:Qual Life Res

Author:

Palandri Francesca,Benevolo Giulia,Iurlo Alessandra,Abruzzese Elisabetta,Carella Angelo M.,Paoli Chiara,Palumbo Giuseppe A.,Bonifacio Massimiliano,Cilloni Daniela,Andriani Alessandro,Guarini Attilio,Turri Diamante,Elli Elena Maria,Falcone Antonietta,Anaclerico Barbara,Musto Pellegrino,Di Renzo Nicola,Tiribelli Mario,Zambello Renato,Spinosa Caterina,Ricco Alessandra,Raucci Letizia,Martino Bruno,Annunziata Mario,Pascale Silvia,Liberati Anna Marina,La Nasa Giorgio,Maffioli Margherita,Breccia Massimo,Pugliese Novella,Betti Silvia,Giglio Gianfranco,Cappuccio Antonietta,Reale Luigi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/article/10.1007/s11136-018-1827-2/fulltext.html

Reference48 articles.

1. Smith, R. E., Chelmowski, M. K., & Szabo, E. J. (1990). Myelofibrosis: A review of clinical and pathologic features and treatment. Critical Reviews in Oncology/Hematology, 10, 305.

2. Campbell, P. J., & Green, A. R. (2006). The myeloproliferative disorders. The New England Journal of Medicine, 355, 2452.

3. Lataillade, J. J., Pierre-Louis, O., Hasselbalch, H. C., et al. (2008). Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence. Blood, 112, 3026.

4. Mesa, R. A., Verstovsek, S., & Cervantes, F. (2007). Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT). Leukemia Research, 31(6), 737–740.

5. Ciurea, S. O., Merchant, D., Mahmud, N., et al. (2007). Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood, 110, 986.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical narrative ability and humanistic care ability of Chinese clinical nurses: The mediating role of empathy ability;Journal of Evaluation in Clinical Practice;2024-08-07

2. Carga socioeconómica de la mielofibrosis en pacientes con y sin anemia en España;Economía de la Salud;2023-12

3. Effects of multidisciplinary rehabilitation in a patient with Ehlers-Danlos and Behçet’s syndromes: a paradigmatic case report according to the narrative medicine;Disability and Rehabilitation;2023-11-19

4. Exploring disease perception in Behçet’s syndrome: combining a quantitative and a qualitative study based on a narrative medicine approach;Orphanet Journal of Rare Diseases;2023-03-18

5. Disabled, invisible and dismissed—The lived experience of fatigue in people with myeloproliferative neoplasms;Cancer Reports;2022-06-15